HeartMasters

HeartMasters was an Israeli medical device startup dedicated to developing percutaneous solutions for mitral valve repair. The company's core technology focused on a catheter-delivered annuloplasty device designed to treat patients suffering from mitral regurgitation, a condition where the heart's mitral valve does not close tightly. This approach aimed to provide a less invasive alternative to traditional open-heart surgery, potentially reducing recovery times and surgical risks for high-risk cardiac patients. Founded by experts in cardiology, including Dr. Amir Lerman, the company operated out of Israel's medtech hub. In 2011, HeartMasters was acquired by Edwards Lifesciences, a global leader in structural heart disease and critical care monitoring. The acquisition allowed Edwards to integrate HeartMasters' intellectual property into its broader strategy for transcatheter valve therapies.